
Sign up to save your podcasts
Or


Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
145145 ratings
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.

977 Listeners

2,175 Listeners

1,993 Listeners

2,672 Listeners

1,105 Listeners

2,342 Listeners

943 Listeners

797 Listeners

208 Listeners

150 Listeners

435 Listeners

355 Listeners

300 Listeners

187 Listeners

475 Listeners